| Aug 9 |
Amicus Therapeutics, Inc. (FOLD) Q2 2024 Earnings Call Transcript
|
| Aug 9 |
Amicus Therapeutics (FOLD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
|
| Aug 8 |
Amicus Therapeutics (FOLD) Q2 Earnings and Revenues Top Estimates
|
| Aug 8 |
Amicus Therapeutics: Q2 Earnings Snapshot
|
| Aug 8 |
Amicus Therapeutics Non-GAAP EPS of $0.06 beats by $0.04, revenue of $126.67M beats by $5.43M
|
| Aug 8 |
Amicus Therapeutics Announces Second Quarter 2024 Financial Results and Corporate Updates
|
| Aug 7 |
Amicus Therapeutics Q2 2024 Earnings Preview
|
| Jul 30 |
Amicus Therapeutics to Announce Second Quarter 2024 Financial Results on August 8, 2024
|
| Jun 7 |
Investors in Amicus Therapeutics (NASDAQ:FOLD) from a year ago are still down 19%, even after 3.9% gain this past week
|
| Jun 5 |
Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
|
